• Global orphan dermatology products market to beat $6B by 2024 biospectrumasia
    September 04, 2018
    "In 2017 only one company was generating more than 10% of its overall revenue from the orphan and rare dermatology therapy area. However, by 2024 there will be several companies generating more than 85% of their revenue from the therapy area.”
PharmaSources Customer Service